Abnormal Biomarkers of Homocysteine Metabolism in Neonates with Conotruncal Heart Defects

Table 1

Demographic characteristics of investigated neonates and their mothers.

Variable	Conotruncal heart defects ()	Nonconotruncal heart defects ()	Controls; ()	value
Mothers
(i) Age (years)	26	29	31	0.5
(ii) Primigravida	26, 60.5%	27, 67.5%	35, 59.3%	0.4
(iii) Dietary supplementation of folic acid	37, 86.0%	35, 87.5%	53, 89.8%	0.3
(iv) Delivery mode: caesarean section	26, 60.5%	22, 55.0%	30, 50.8%	0.1
Newborns
(i) Gender female	20, 46.5%	23, 57.5%	30, 50.8%	0.7
(ii) Gestational age (weeks)	38.5	37	39.5	0.6
(iii) Birth weight (g)	3090	3313	3230	0.4
(iv) Head circumference (cm)	34.5	34.5	34.0	0.1
(v) Body length (cm)	53.0	54.5	53.5	0.5
(vi) Apgar 1st min
0–3 pts	2, 4.7%	1, 2.3%	0	0.6
4–7 pts	5, 11.6%	8, 20.0%	8, 13.6%
8–10 pts	36, 83.7%	32, 80.0%	51, 86.4%
(vii) Apgar 5th min
0–3 pts	0	0	0	0.5
4–7 pts	2, 4.7%	6, 15.0%	5, 8.5%
8–10 pts	41, 95.3%	34, 85.0%	54, 81.5%

Results are shown as mean and standard deviation SD or percentile; value from Kruskal-Wallis test or chi square test.